Skip to main content

Want a detailed portfolio tracker?

Molecular Partners (MOLN) P/E (2021 - 2026)

Molecular Partners (MOLN) P/E from Jun 16, 2021 to Jul 20, 2026. The TTM Molecular Partners (MOLN) P/E is -1.85. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Molecular Partners (MOLN)

YearP/EChange
2026-1.85-2.52%
2025-1.90-26.44%
2024-2.59+27.20%
2023-2.03-215.38%
20221.76-122.44%
2021-7.85N/A

Comparison Molecular Partners (MOLN) P/E with competitors

Molecular Partners (MOLN) P/E is -1.85.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.09%
NBYStablecoin Development Corp0.00-100.23%
ENLVEnlivex Ltd0.07-104.03%
FGENFibroGen Inc0.24-112.95%
CHRSCoherus Biosciences Inc0.85-145.76%
FBIOFortress Biotech Inc0.95-151.18%
ORMPOramed Pharmaceuticals Inc1.50-181.06%
AGENAgenus Inc3.01-262.31%
INVAInnoviva Inc3.15-270.09%
VXRTVaxart Inc3.55-291.43%
CRMDCorMedix Inc3.63-295.68%
CVACCureVac N.V.4.45-339.75%
GLPGGalapagos NV4.86-362.03%
SRPTSarepta Therapeutics Inc4.88-363.29%
ABEOAbeona Therapeutics Inc5.39-390.54%
ABUSArbutus Biopharma Corp5.60-401.77%
ZVRAZevra Therapeutics Inc5.89-417.49%
SPROSpero Therapeutics Inc6.23-435.89%
CGENCompugen Ltd6.31-440.50%
RIGLRigel Pharmaceuticals6.87-470.60%
SLXNSilexion Therapeutics Corp7.30-493.47%
OMEROmeros Corporation9.26-599.32%
AUPHAurinia Pharmaceuticals Inc9.58-616.91%
PLXProtalix BioTherapeutics Inc10.89-687.34%
ACADAcadia Pharmaceuticals Inc11.73-732.51%
TBPHTheravance Biopharma Inc12.26-761.29%
ADMAAdma Biologics Inc12.42-769.70%
HRMYHarmony Biosciences Holdings Inc13.82-845.31%
SABSSAB Biotherapeutics Inc14.14-862.35%
NAGENiagen Bioscience Inc14.82-899.13%
INCYIncyte Corp15.82-953.30%
REGNRegeneron Pharmaceuticals Inc15.86-955.14%
PBYIPuma Biotechnology Inc17.32-1033.82%
CPRXCatalyst Pharmaceuticals Inc17.44-1040.49%
EXELExelixis Inc17.54-1045.81%
TGTXTG Therapeutics Inc18.97-1122.82%
MDXGMimedx Group Inc20.55-1208.38%
XOMAXOMA Royalty Corp22.87-1333.65%
ARGXArgen X SE24.30-1410.41%
CTMXCytomX Therapeutics Inc24.82-1438.62%
XOMAOXOMA Royalty Corp25.34-1466.86%
HALOHalozyme Therapeutics Inc25.62-1481.90%
XOMAPXOMA Royalty Corp25.67-1484.41%
VRTXVertex Pharmaceuticals Inc27.99-1609.77%
RPRXRoyalty Pharma plc - Class A28.69-1647.14%
SLNOSoleno Therapeutics Inc29.02-1664.82%
ASNDAscendis Pharma A/S30.09-1722.53%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2144.62%
APLSApellis Pharmaceuticals Inc39.02-2204.44%
BMRNBiomarin Pharmaceutical Inc42.21-2376.51%
KRYSKrystal Biotech Inc45.34-2545.40%
ONCBeiGene Ltd69.54-3850.36%
PHARPharming Group N.V.75.03-4146.18%
TECHBio-Techne Corp101.96-5598.68%
VCELVericel Corp109.92-6028.13%
ALNYAlnylam Pharmaceuticals Inc117.96-6461.93%
GMABGenmab140.29-7665.97%
TLXTelix Pharmaceuticals Ltd162.15-8845.01%
CORTCorcept Therapeutics Inc212.86-11579.55%